Found: 69
Select item for more details and to access through your institution.
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Application of the Rotterdam postoperative cerebellar mutism syndrome prediction model in patients undergoing surgery for medulloblastoma in a single institution.
- Published in:
- Journal of Neurosurgery: Pediatrics, 2024, v. 33, n. 2, p. 174, doi. 10.3171/2023.9.PEDS23160
- By:
- Publication type:
- Article
1 Ototoxicity and Cognitive Outcomes among Children Treated for Brain Tumors in Infancy.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Cerebral glucose metabolism on positron emission tomography of children.
- Published in:
- Human Brain Mapping, 2014, v. 35, n. 5, p. 2297, doi. 10.1002/hbm.22328
- By:
- Publication type:
- Article
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 4, p. 423, doi. 10.1038/ng0415-423
- By:
- Publication type:
- Article
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 263, doi. 10.1038/ng.3217
- By:
- Publication type:
- Article
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
- Published in:
- Nature Genetics, 2014, v. 46, n. 5, p. 444, doi. 10.1038/ng.2938
- By:
- Publication type:
- Article
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors.
- Published in:
- Child's Nervous System, 2015, v. 31, n. 9, p. 1433, doi. 10.1007/s00381-015-2812-5
- By:
- Publication type:
- Article
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.
- Published in:
- Child's Nervous System, 2015, v. 31, n. 8, p. 1283, doi. 10.1007/s00381-015-2725-3
- By:
- Publication type:
- Article
A high‐dimensional mediation model for a neuroimaging mediator: Integrating clinical, neuroimaging, and neurocognitive data to mitigate late effects in pediatric cancer.
- Published in:
- Biometrics, 2023, v. 79, n. 3, p. 2430, doi. 10.1111/biom.13729
- By:
- Publication type:
- Article
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 12, p. 1589, doi. 10.1007/s00262-017-2051-6
- By:
- Publication type:
- Article
Pharmacokinetic basis for dosing high‐dose methotrexate in infants and young children with malignant brain tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 2, p. 362, doi. 10.1111/bcp.14160
- By:
- Publication type:
- Article
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 10, p. 1777, doi. 10.1093/neuonc/noab047
- By:
- Publication type:
- Article
Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1586, doi. 10.1093/neuonc/noab030
- By:
- Publication type:
- Article
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1696, doi. 10.1093/neuonc/noaa119
- By:
- Publication type:
- Article
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 875, doi. 10.1093/neuonc/noaa016
- By:
- Publication type:
- Article
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1319, doi. 10.1093/neuonc/noz069
- By:
- Publication type:
- Article
LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii98, doi. 10.1093/neuonc/noz036.145
- By:
- Publication type:
- Article
PDCT-07. FEASIBILITY TRIAL OF TTFIELDS (TUMOR TREATING FIELDS) FOR CHILDREN WITH RECURRENT OR PROGRESSIVE SUPRATENTORIAL HIGH-GRADE GLIOMA (HGG) AND EPENDYMOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY: PBTC-048.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi201, doi. 10.1093/neuonc/noy148.837
- By:
- Publication type:
- Article
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1135, doi. 10.1093/neuonc/now282
- By:
- Publication type:
- Article
Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 12, p. 1620, doi. 10.1093/neuonc/nov181
- By:
- Publication type:
- Article
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 12, p. 1661, doi. 10.1093/neuonc/nou103
- By:
- Publication type:
- Article
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 6, p. 848, doi. 10.1093/neuonc/not241
- By:
- Publication type:
- Article
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 2, p. 310, doi. 10.1093/neuonc/not154
- By:
- Publication type:
- Article
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma—a Pediatric Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 11, p. 1404, doi. 10.1093/neuonc/nos213
- By:
- Publication type:
- Article
PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 9, p. 1146, doi. 10.1093/neuonc/nos140
- By:
- Publication type:
- Article
Sample size calculation for recurrent event data with additive rates models.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 89, doi. 10.1002/pst.2154
- By:
- Publication type:
- Article
Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.
- Published in:
- Brain Pathology, 2018, v. 28, n. 1, p. 112, doi. 10.1111/bpa.12484
- By:
- Publication type:
- Article
Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 677, doi. 10.2967/jnumed.118.219998
- By:
- Publication type:
- Article
Correlation of <sup>18</sup>F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1264, doi. 10.2967/jnumed.116.185389
- By:
- Publication type:
- Article
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02027-6
- By:
- Publication type:
- Article
Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 27, doi. 10.1007/s00280-014-2614-6
- By:
- Publication type:
- Article
Attainment and retention of force moderation following laparoscopic resection training with visual force feedback.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Auditory Outcomes in Patients Who Received Proton Radiotherapy for Craniopharyngioma.
- Published in:
- American Journal of Audiology, 2018, v. 27, n. 3, p. 306, doi. 10.1044/2018_AJA-18-0026
- By:
- Publication type:
- Article
Feasibility and Efficacy of a Computer-Based Intervention Aimed at Preventing Reading Decoding Deficits Among Children Undergoing Active Treatment for Medulloblastoma: Results of a Randomized Trial.
- Published in:
- Journal of Pediatric Psychology, 2014, v. 39, n. 4, p. 450, doi. 10.1093/jpepsy/jst095
- By:
- Publication type:
- Article
Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31208
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30600
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30600
- By:
- Publication type:
- Article
Photon versus proton whole ventricular radiotherapy for non‐germinomatous germ cell tumors: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 9, p. 1, doi. 10.1002/pbc.29697
- By:
- Publication type:
- Article
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28879
- By:
- Publication type:
- Article
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 2, p. 1, doi. 10.1002/pbc.28756
- By:
- Publication type:
- Article
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Concordance between the chang and the International Society of Pediatric Oncology ( SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 4, p. 601, doi. 10.1002/pbc.24830
- By:
- Publication type:
- Article
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 3, p. 543, doi. 10.1007/s00401-023-02614-9
- By:
- Publication type:
- Article
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 2, p. 259, doi. 10.1007/s00401-019-02106-9
- By:
- Publication type:
- Article
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF<sup>V600E</sup> mutation.
- Published in:
- Acta Neuropathologica, 2019, v. 137, n. 4, p. 683, doi. 10.1007/s00401-019-01987-0
- By:
- Publication type:
- Article
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 2, p. 299, doi. 10.1007/s00401-015-1532-y
- By:
- Publication type:
- Article